Cargando…
Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography
PURPOSE: To evaluate the effectiveness of intravitreal bevacizumab treatment in patients with diabetic macular edema (DME) by assessing retinal changes using optical coherence tomography angiography (OCT-A). METHODS: This prospective study was performed in patients with treatment-naïve DME. The eyes...
Autores principales: | Hunt, Magdalena, Teper, Sławomir, Wylęgała, Adam, Wylęgała, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885291/ https://www.ncbi.nlm.nih.gov/pubmed/35237693 http://dx.doi.org/10.1155/2022/3547461 |
Ejemplares similares
-
1-Year Fixed-Regimen Bevacizumab Treatment in DME-Vascular Network Image Analysis in Optical Coherence Tomography Angiography Study
por: Hunt, Magdalena, et al.
Publicado: (2022) -
Optical coherence angiography: A review
por: Wylęgała, Adam, et al.
Publicado: (2016) -
Assessment of the Retinal Vessels in Keratoconus: An OCT Angiography Study
por: Wylęgała, Adam, et al.
Publicado: (2022) -
How to Achieve Near-Normal Visual Acuity with Bevacizumab in Diabetic Macular Edema Patients
por: Sędziak-Marcinek, Bogumiła, et al.
Publicado: (2021) -
Diabetic Macular Edema Treatment with Bevacizumab Does Not Depend on the Retinal Nonperfusion Presence
por: Sędziak-Marcinek, Bogumiła, et al.
Publicado: (2021)